Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could ...

Cancer has long been medicine’s most elusive target, but a wave of new research suggests scientists may finally be closing in ...

At the Cleveland Clinic, researchers are testing a preventive breast cancer vaccine, and results from Phase 1 of the trial are showing promising signs.

In a Phase 1 trial, women responded well to the novel vaccine. More research is needed to determine whether it can stop the cancer from recurring or possibly prevent it entirely.

Cleveland Clinic researchers are presenting final Phase I data from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease ...

Although great strides have been made in research for breast cancer vaccines, such a vaccine is likely years away from ...

A recent breast cancer vaccine brings good news for women. The jab could help prevent Triple-negative breast cancer (TNBC) before it starts. Plus, it could reduce harsh treatments, empower high-risk ...

The trial targeting triple-negative breast cancer, which disproportionately affects Black women, induced immune responses in ...

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine.

Here’s what’s on the CBC Health Unit’s watch list for 2026: New approaches to connecting people with family doctors, ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...

In a statement accompanying the announcement of Risch to the cancer panel, HHS Secretary Robert F. Kennedy Jr. — himself a ...